logo

Essex Bio

Sector: Water Supply and Storage • Location: China

Source: International Finance Corporation (IFC)

Project
Completed

The proposed project involves IFC providing a convertible loan to Essex Bio-Technology Limited (“Essex” or the “Company”), which is a market leader in the development, production, and sale of biopharmaceutical drugs in China. These drugs are used in the treatment of surface wounds and a variety of eye diseases and are based on basic fibroblast growth factor (bFGF) technology. Essex is a research a

Project Information FAQ

Project Information

5 Q
The project “Essex Bio” is an infrastructure initiative in the Water Supply and Storage sector, located in China. Taiyo aggregates data on it from International Finance Corporation (IFC).

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

completed

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

The proposed project involves IFC providing a convertible loan to Essex Bio-Technology Limited (“Essex” or the “Company”), which is a market leader in the development, production, and sale of biopharmaceutical drugs in China. These drugs are used in the treatment of surface wounds and a variety of eye diseases and are based on basic fibroblast growth factor (bFGF) technology. Essex is a research and development (R&D) driven pharmaceutical company and holds seven innovative patents. The majority of its drugs are Category I drugs in China, meaning that they are (i) new and innovative; (ii) have not been approved or launched in any other country yet; and (iii) with a period of patent protection until 2030 and market exclusivity. The Company plans to continue investing in R&D, increase its sales-force, and improve its working capital management (the “Project”) with a total project cost of about US$45 million equivalent.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data